Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
5
Neutral
4
Bullish
5
Bearish
37
Neutral
4
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Discovery themes featuring this stockScrutinizer Report
Scrutinizer's report confirms the 1st EGM held via VC/OAVM on 27-Apr-2026; remote e‑voting and e‑voting at the meeting were conducted and results reported for resolutions including appointment of an independent director and approval of a material related‑party transaction.
EGM Scrutinizer Report
Scrutinizer's report confirms Bandaram Pharma Packtech Ltd held its EGM via VC/OAVM on 27-Apr-2026; resolutions including appointment of an independent director and approval of a material related‑party transaction with Visit Paper & Packaging Ltd (subsidiary) were approved by shareholders via remote e‑voting and e‑voting at the meeting (resolution 2 recorded 2,581,655 votes in favour: remote 2,343,653; e‑voting at EGM ~210,002).
EGM Outcome
Bandaram Pharma Packtech held its 1st EGM on 27‑Apr‑2026 (VC) where 3 resolutions were passed — appointment of Mr. Eswar Reddy Putturu as Independent Director and approval of material and one‑time related‑party transactions with subsidiary VSR Paper and Packaging Ltd; meeting ran 11:27–11:37 with 34 attendees.
EGM outcome
Bandaram Pharma Packtech held an EGM on 27-Apr-2026 (11:27–11:37 IST) where shareholders passed three resolutions: appointment of Mr. Eswar Reddy Putturu as Independent Director and approval of material and one‑time material RPTs with subsidiary VSR Paper And Packaging Ltd.
Bandaram Pharma Packtech Ltd (BANDARAM) is currently trading at 25.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Bandaram Pharma Packtech Limited primarily focuses on the processing and supply of recycled paper to mills in Andhra Pradesh. Originally a latex glove manufacturer, the company has pivoted entirely to the paper industry since 2022. The company meticulously ensures only high-quality recycled paper enters production, which supports efficient pulping for manufacturers. This includes sorting and baling consumer waste paper collected by hawkers and dealers. The company expanded its operations through the acquisition of VSR Paper and Packaging Limited in April 2022, bolstering its capabilities in the recycled paper sector. The company has a historical footprint in latex glove manufacturing, with a previous emphasis on exporting to international markets, before its strategic shift to recycled paper. The company's operational shift underscores a strategic realignment towards sustainable markets, leveraging local supply chains in Andhra Pradesh.
Over the past 52 weeks, Bandaram Pharma Packtech Ltd has traded between a low of ₹22.00 and a high of ₹49.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Bandaram Pharma Packtech Ltd has a market capitalization of approximately 48.81. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Bandaram Pharma Packtech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 125.15 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 48.81 Cr, Bandaram Pharma Packtech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Bandaram Pharma Packtech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Bandaram Pharma Packtech Ltd is 125.15. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bandaram Pharma Packtech Limited primarily focuses on the processing and supply of recycled paper to mills in Andhra Pradesh. Originally a latex glove manufacturer, the company has pivoted entirely to the paper industry since 2022.
The company meticulously ensures only high-quality recycled paper enters production, which supports efficient pulping for manufacturers. This includes sorting and baling consumer waste paper collected by hawkers and dealers.
The company expanded its operations through the acquisition of VSR Paper and Packaging Limited in April 2022, bolstering its capabilities in the recycled paper sector.
The company has a historical footprint in latex glove manufacturing, with a previous emphasis on exporting to international markets, before its strategic shift to recycled paper.
The company's operational shift underscores a strategic realignment towards sustainable markets, leveraging local supply chains in Andhra Pradesh.
Healthcare Services
Healthcare Service Provider
49 Cr
Low Risk
125.2
56.7
30.4
2.0
49.70
22.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
57.01 | 65 Cr | 28.94 | 9.03 | 0.00 | 16.62 | 13.17 | 13.75 | ||
29.50 | 49 Cr | 128.16 | 1.97 | 0.25 | 1.57 | 4.13 | 1.44 | ||
129.00 | 45 Cr | -31.23 | 1.16 | 0.00 | 12.51 | 14.95 | -3.23 | ||
17.08 | 39 Cr | -5.17 | 2.54 | 0.00 | -29.86 | -30.51 | -47.38 | ||
101.95 | 34 Cr | 28.32 | 2.76 | 0.00 | 9.84 | 10.99 | 3.78 | ||
15.44 | 32 Cr | 24.90 | 1.22 | 0.00 | 6.34 | 9.29 | 4.08 | ||
35.75 | 30 Cr | -32.80 | 0.00 | 0.00 | 35.31 | -0.76 | -3.69 | ||
| Median: 7 Co. | — | 35.75 | 39 Cr | 24.90 | 1.97 | 0.00 | 9.84 | 9.29 | 1.44 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
